Research Article310.4161/hv.6.11.13034Simplified β-amyloid peptides for safer Alzheimer’s vaccines developmentNov 01, 2010Human VaccinesAntonio Verdoliva + 2 more +2CiteListenSave
Front Matter10.4161/hv.6.10.13824The path to developing a cervical cancer vaccineOct 01, 2010Human VaccinesKathrin U JansenCiteListenSave
Research Article4210.4161/hv.6.9.12571Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.Sep 01, 2010Human VaccinesVladimir Mulens + 14 more +14CiteListenSave
Front Matter10.4161/hv.6.8.13187Letter from the EditorAug 01, 2010Human VaccinesRonald W Ellis + 1 more +1CiteListenSave
News Article10.4161/hv.6.7.12824Therapeutic CMV vaccine: Promising Phase II trialJul 01, 2010Human VaccinesEva M RiedmannCiteListenSave
Front Matter110.4161/hv.6.5.12002Evidence versus expert opinion in vaccination practiceMay 01, 2010Human VaccinesIan F CookCiteListenSave
Supplementary Content1010.4161/hv.6.5.11180Rotavirus vaccines for global use: What are the remaining issues and challenges?May 01, 2010Human VaccinesBaoming Jiang + 2 more +2CiteListenSave
Research Article1810.4161/hv.6.5.10755Recent advances in the field of Salmonella Typhi vaccinesMay 01, 2010Human VaccinesGavin K Paterson + 1 more +1CiteListenSave